Type 2 Diabetes (2nd Ed.) Principles and Practice, Second Edition
Coordonnateurs : Goldstein Barry J., Mueller-Wieland Dirk
Epidemiology of Type 2 Diabetes. Pathogenesis of Type 2 Diabetes. Rationale and Goals for Glucose Control in Diabetes and Glucose Monitoring. Role of the Diabetes Educator in the Management of Diabetes. Nutrition in the Etiology and Management of Type 2 Diabetes.
Exercise in Diabetes. Psychosocial Issues and Type 2 Diabetes. Insulin Secretion Enhancers: Sulfonylureas and Meglitinides. Metformin. Glucosidase Inhibitors. Thiazolidinediones.
Insulin Treatment in Type 2 Diabetes. Combination Therapy for Treatment of Type 2 Diabetes.
Hypoglycemia in Type 2 Diabetes. Metabolic Emergencies in Type 2 Diabetes: Hyperosmolar Non-Ketotic Hyperglycemia, Ketoacidosis and Lactic Acidosis. Diabetic Retinopathy and Ocular Complications. Renal Dysfunction and Nephropathy In Type 2 Diabetes. Diabetic Peripheral Neuropathy and Sexual Function. Diabetic Foot - Assessment, Management and Prevention.
Gastrointestinal and Autonomic Complications of Type 2 Diabetes. Urogenital (Bladder and Sexual Dysfunction). Skin, Subcutaneous Tissues, Infections. Gestational Diabetes. Type 2 Diabetes in Children and Adolescents. The Insulin Resistance Syndrome and Its Vascular Complications. Obesity - Influence on Diabetes and Management. Dyslipidemia and Diabetes.
Antihypertensive Therapy in Diabetes. Cardiac and Peripheral Vascular Disease Evaluation. CHD (Should Include ACS, MI, Heart Failure, and Stable CAD..Specific Considerations in Diabetes). Stroke. Peripheral Vascular Disease. Anesthesia and Surgery in the Diabetic Patient.
Type 2 Diabetes: Geriatric Considerations. Diabetes in High-Risk Ethnic Populations. Diabetes Secondary to Drug, Hormones and Other Endocrinopathies. Rare Forms of Diabetes (MODY).
PCO Syndrome. NASH and Diabetes. New Devices and Drugs on the Horizon
Date de parution : 09-2019
17.8x25.4 cm
Date de parution : 11-2007
Ouvrage de 608 p.
17.8x25.4 cm
Thèmes de Type 2 Diabetes :
Mots-clés :
Insulin Resistance; Glycemic Control; OGTT; Insulin Secretion; Insulin Therapy; Risk Factor; Diabetic Patients; DPP Iv Inhibitor; Non-diabetic Patients; Postprandial Glucose; T2 Dm Patient; Insulin Glargine; GLP-1 Agonist; Incretin Mimetics; Diabetic Retinopathy; T2 Dm; GLP-1 Receptor Agonist; Basal Insulin; Oral Agents; Oral Antidiabetic Drugs; Progressive Disease; Alpha Glucosidase Inhibitors; Tight BG Control; Ace Inhibitor; Insulin Secretagogues